Table: SymBio Pharmaceuticals -2019 parent results

SymBio Pharmaceuticals

06/02/2020 06:30

Feb 6 (Reuters)- 
          SymBio Pharmaceuticals Limited 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                  Year ended       Year ended        Year to         NEXT   
               Dec 31, 2019     Dec 31, 2018     Dec 31, 2020      YEAR     
                  LATEST          YEAR-AGO         COMPANY        COMPANY   
                 RESULTS          RESULTS          FORECAST     H1 FORECAST 
  Sales            2.84             3.84             3.40                   
               (-26.0 pct)      (+11.4 pct)      (+20.0 pct)                
  Operating     loss 4.30        loss 2.66        loss 5.09                 
  Recurring     loss 4.38        loss 2.75        loss 5.13                 
  Net           loss 4.38        loss 2.75        loss 4.80                 
  EPS        loss 189.03 yen  loss 165.54 yen  loss 181.84 yen              
  Ann Div          NIL              NIL              NIL                    
  -Q2 Div          NIL              NIL              NIL                    
  -Q4 Div          NIL              NIL              NIL                    
  
  NOTE - SymBio Pharmaceuticals Limited. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4582.T